Fungal Infection: Clinical Trials

95 trials for Fungal Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

62 completed, 15 unknown, 6 terminated, 5 recruiting. 19 Phase 1, 14 Phase 3, 13 Phase 2, 12 Phase 4, 6 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 119Completed 16, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 314Completed 12, Enrolling by invitation 1, Recruiting 1
Phase 213Completed 8, Unknown 3, Recruiting 1, Withdrawn 1
Phase 412Completed 7, Terminated 3, Not yet recruiting 1, Recruiting 1
Not applicable6Unknown 3, Completed 2, Recruiting 1

Follow Fungal Infection: new trials by email Literature Review of Fungal Infection trials Research Report on Fungal Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD5CAR-NK Cells for Refractory Invasive Mold Disease
CD5CAR-CBNK - Fungal Infection
Phase 1Not yet recruitingFundacion Clinic per a la Recerca Biomédica102026-05-012026-03-06
Fungal Vascular Graft Infections, French Multicenter Retrospective Study
epidemiology and medical treatment strategies - Fungal Infection, Vascular Grafting
Not yet recruitingUniversity Hospital, Bordeaux3002026-01-012025-12-16
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Rezafungin Prophylaxis in Liver Transplant
Rezafungin, Standard of care antifungal prophylaxis - Liver Transplant Infection, Fungal Infection
Phase 3Enrolling by invitationFernanda P Silveira, MD, MS3852025-10-152026-09-29
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
Liver Cirrhosis, Viral Pneumonia
Active not recruitingUniversitaire Ziekenhuizen KU Leuven4502025-08-012026-03-04
Isavuconazole in Critically Ill Patients: Efficacy and Safety
Isavuconazole treatment - Fungal Infection, Aspergillosis
Not yet recruitingShanghai 10th People's Hospital752025-08-012025-07-23
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy
Phase 2RecruitingThe University of Queensland1042025-04-142026-04-16
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Single high dose of liposomal amphotericin B, L-AmB standard dose - Disseminated Histoplasma Capsulatum Infection, AIDS and Infections
Phase 3RecruitingFederal University of Health Science of Porto Alegre2792025-01-162026-07-27
Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm
Individualization of first voriconazole maintenance doses - Aspergillosis Invasive, Fungal Infection
Phase 4Not yet recruitingUniversity Hospital, Grenoble302024-10-012024-09-03
Topical Application of Essential Oils to Treat Onchomycosis
Onychomycosis of Toenail, Fungal Infection
UnknownMedical Life Care Planners, LLC502024-05-302024-05-16
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
Acute Lymphoblastic Leukemia, Infections
UnknownGruppo Italiano Malattie EMatologiche dell'Adulto1582024-04-042024-04-11
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
Fungal Infection
UnknownAssiut University1002024-01-012024-01-30
The Assessment of Antimicrobial Peptides Against Fungal Infection
Fungal Infection
UnknownAssiut University1002022-12-012022-05-10
Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
biological - Bronchopulmonary Dysplasia, Extreme Prematurity
CompletedCentre Hospitalier Sud Francilien1532022-03-212024-11-26
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
Fungal Infection, Candidiasis
CompletedMayo Clinic872022-02-102024-10-09
An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
CGB-400 Topical Gel - Fungal Infection, Onychomycosis
CompletedCAGE Bio Inc.152022-02-082026-04-02
Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
Fungal Infection
CompletedUniversity Hospital, Strasbourg, France3002021-10-292024-09-19
Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases
sample collection (swap or tape strip) - Fungal Infection, Inflammatory Skin Disease
Not applicableUnknownZealand University Hospital7002021-09-012021-07-20
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
BB2603-1, BB2603-3, BB2603-10 - Distal Subungual Onychomycosis, Fungal Infection
Phase 2CompletedBlueberry Therapeutics1112021-03-222023-08-01
COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Observation to monitor patients for these infections - Covid19, Aspergillosis
CompletedUniversity of Alabama at Birmingham2192021-03-092026-01-16

Showing 20 of 95. Sign in to see all of them.

Narrower conditions

Mycoses (95)  ·  Invasive Fungal Infections (9)  ·  Hematologic Neoplasms (6)  ·  Infections (6)  ·  Aspergillosis (5)  ·  Bacterial Infections (5)  ·  Candidiasis (5)  ·  Leukemia (5)  ·  Neutropenia (5)  ·  Candidiasis, Invasive (4)  ·  Leukemia, Myeloid, Acute (4)  ·  Sepsis (4)  ·  Candidemia (3)  ·  Fungemia (3)  ·  Myelodysplastic Syndromes (3)

Broader conditions

Bacterial Infections and Mycoses (95)  ·  Infections (89)  ·  Hematologic Diseases (17)  ·  Hemic and Lymphatic Diseases (17)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Neoplasms (13)  ·  Pathologic Processes (11)  ·  Neoplasms by Histologic Type (9)  ·  Immune System Diseases (8)  ·  Neoplasms by Site (7)  ·  Agranulocytosis (6)  ·  Cytopenia (6)  ·  Leukocyte Disorders (6)  ·  Leukopenia (6)  ·  Lung Diseases (6)

Interventions

Caspofungin (15)  ·  posaconazole (12)  ·  Voriconazole (9)  ·  Fluconazole (8)  ·  Rezafungin (4)  ·  Injections (3)  ·  liposomal amphotericin B (3)  ·  Amphotericin B (2)  ·  Blood Specimen Collection (2)  ·  Anidulafungin (1)  ·  Biological Products (1)  ·  Diagnostic Imaging (1)  ·  Dimethyl Sulfoxide (1)  ·  Duration of Therapy (1)  ·  Glucose (1)

Sponsors

Merck Sharp & Dohme LLC (11)  ·  Assiut University (6)  ·  Basilea Pharmaceutica (4)  ·  University of Pittsburgh (4)  ·  Children's Oncology Group (3)  ·  Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2)  ·  M.D. Anderson Cancer Center (2)  ·  Pfizer (2)  ·  Seoul National University Hospital (2)  ·  University of Alabama at Birmingham (2)  ·  AM-Pharma (1)  ·  Ain Shams University (1)  ·  Azienda Ospedaliero-Universitaria Careggi (1)  ·  Bayside Health (1)  ·  Blueberry Therapeutics (1)

Countries

United States (28)  ·  France (10)  ·  Italy (8)  ·  Netherlands (7)  ·  Spain (7)  ·  Belgium (6)  ·  Canada (6)  ·  Germany (6)  ·  China (5)  ·  Australia (4)  ·  South Korea (3)  ·  Thailand (3)  ·  United Kingdom (3)  ·  Bulgaria (2)  ·  Czechia (2)

Top investigators

Marc Engelhardt (4)  ·  Jorge Cortes, MD (2)  ·  Angela Smith, M.D. (1)  ·  Asuncion Moreno, MD (1)  ·  Blair Capitano, Pharm D (1)  ·  Carl Brown, PhD (1)  ·  Carlos Cervera, MD (1)  ·  Catherine Hardalo, MD (1)  ·  Charussri Leeyaphan, MD (1)  ·  Christopher C Dvorak (1)

Results publications

PMID 33438477, PMID 36988461, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006, PMID 10233295, PMID 10642676, PMID 14723731, PMID 18809946, PMID 19593252, PMID 20347657, PMID 20667889, PMID 21820203, PMID 22236569, PMID 22290953, PMID 22324990, PMID 22976905, PMID 23052987, PMID 23400742, PMID 23416171, PMID 23459494, PMID 24079583, PMID 24373120, PMID 24733463, PMID 25013957, PMID 25639524, PMID 25645660, PMID 26471716, PMID 27799043, PMID 27815659, PMID 28936678, PMID 28961714, PMID 31688884, PMID 32319040, PMID 32601169, PMID 32737088, PMID 32955088, PMID 33136159, PMID 34970774, PMID 35167031, PMID 35906831, PMID 36442484, PMID 37232940, PMID 37773627, PMID 38757982, PMID 38985561, PMID 39010708, PMID 39012090

NIH funding

U10CA095861 (3), 2017 (2), UG1CA189955 (2), 2009 (1), 2015 (1), 2018 (1), 2025 (1), 5UL1RR024982-02 (1)